| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100345 | Journal of Crohn's and Colitis | 2011 | 4 Pages |
Abstract
⺠An increased risk for developing demyelinating diseases has been reported in IBD patients. ⺠This is the first case of GBS developing in a IBD patient following ADA use. ⺠Patients receiving TNF-α antagonists should be monitored for neurologic signs and symptoms suggestive of demyelinating disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Monica Cesarini, Erika Angelucci, Tiziana Foglietta, Piero Vernia,